Tanaka Shinobu, Okamoto Yasuyuki, Yamazaki Masaharu, Mitani Noriaki, Nakqjima Yoshiyuki, Fukui Hiroshi
Central Clinical Laboratory, Nara Medical University Hospital, Japan.
Hepatogastroenterology. 2007 Dec;54(80):2301-5.
BACKGROUND/AIMS: Although hyperglobulinemia is frequently detected in severe chronic liver diseases (CLD) such as liver cirrhosis (LC), the mechanism for this is still uncertain. Hyperglobulinemia may represent a functional aspect of the liver.
The correlation between serum globulin (GLB) level and each of various liver function tests including the indocyanine green (ICG) retention rate at 15 min (ICGR15) was studied using 146 patients with liver dysfunction. The correlations among GLB, IgG and ICGR15 were also studied in other 32 patients with LC, in whom the glycosylation pattern of IgG was determined by enzyme-linked immunosorbent assay to detect terminal galactose (Gal) and neuraminic acid (NA) using biotinylated lectins.
GLB level was predominantly correlated with ICGR15 (r = 0.449) among various liver function tests in 146 patients with liver dysfunction. In the 32 patients with LC, strong positive correlations between GLB and IgG (r = 0.875), between GLB and ICGR15 (r = 0.435), and between IgG and ICGR15 (r = 0.557) were evident. The glycosylation pattern of IgG showed that the proportions of both Gal and NA were inversely correlated with serum IgG levels (r = -0.516 and -0.390, respectively) in these patients. Significant decreases of the proportions were found in patients with IgG elevation (> 20 g/L, n = 13).
The correlation between GLB and ICGR15 suggested that hyperglobulinemia is related to a common dysfunction estimated by ICG clearance, which represents mainly the liver's blood flow and removal capacity. The removal of immunoglobulins by the liver may be impaired in patients with severe liver dysfunction because the liver is a major catabolic site for immunoglobulins. The glycation pattern suggested that the proportions of asialo IgG and agalactosyl IgG were increased in the LC patients with IgG elevation possibly by deficient receptor-mediated removal in the liver. Although further investigations will be needed, hyperglobulinemia could be predictive for a certain impaired hepatic function estimated by ICG clearance in severe CLD such as LC.
背景/目的:尽管在诸如肝硬化(LC)等严重慢性肝病(CLD)中经常检测到高球蛋白血症,但其机制仍不确定。高球蛋白血症可能代表肝脏的一种功能表现。
使用146例肝功能不全患者研究血清球蛋白(GLB)水平与包括15分钟吲哚菁绿(ICG)潴留率(ICGR15)在内的各项肝功能检查之间的相关性。在另外32例LC患者中也研究了GLB、IgG和ICGR15之间的相关性,通过酶联免疫吸附测定法使用生物素化凝集素来检测末端半乳糖(Gal)和神经氨酸(NA),以确定这些患者中IgG的糖基化模式。
在146例肝功能不全患者中,各项肝功能检查中GLB水平主要与ICGR15相关(r = 0.449)。在32例LC患者中,GLB与IgG之间(r = 0.875)、GLB与ICGR15之间(r = 0.435)以及IgG与ICGR15之间(r = 0.557)存在明显的强正相关。IgG的糖基化模式显示,这些患者中Gal和NA的比例均与血清IgG水平呈负相关(分别为r = -0.516和-0.390)。在IgG升高(> 20 g/L,n = 13)的患者中发现这些比例显著降低。
GLB与ICGR15之间的相关性表明,高球蛋白血症与通过ICG清除率评估的共同功能障碍有关,ICG清除率主要代表肝脏的血流和清除能力。在严重肝功能不全患者中,肝脏对免疫球蛋白的清除可能受损,因为肝脏是免疫球蛋白的主要分解代谢部位。糖基化模式表明,在IgG升高的LC患者中,去唾液酸IgG和去半乳糖基IgG的比例可能因肝脏中受体介导的清除不足而增加。尽管还需要进一步研究,但高球蛋白血症可能预示着在诸如LC等严重CLD中通过ICG清除率评估的某种肝功能受损。